September 14, 2017 10:19 AM EDT
News Briefing

As­traZeneca auc­tions off more as­sets in $766M deal, re­ports pos­i­tive da­ta for Farx­i­ga

Shehla Shakoor

Managing Director

⇨ As­traZeneca CEO Pas­cal So­ri­ot has sold off an­oth­er set of as­sets. The phar­ma gi­ant is sell­ing a port­fo­lio of anes­thet­ics to As­pen Glob­al for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times